alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
----

----

I Mitteilungen

Kommission

----

Euro-Wechselkurs (1)

25. August 2005

(2005/C 209/01)

1 Euro= 

----

(1)

Quelle: Von der Europäischen Zentralbank veröffentlichter Referenz-Wechselkurs.

----

----

Bekanntmachung über das bevorstehende Außerkrafttreten bestimmter Antidumpingmaßnahmen

(2005/C 209/02)

2.   Verfahren

Die Gemeinschaftshersteller können einen schriftlichen Antrag auf Überprüfung stellen. Dieser Antrag muß genügend Beweise dafür enthalten, daß das Dumping und die Schädigung im Falle des Außerkrafttretens der Maßnahmen wahrscheinlich anhalten oder erneut auftreten würden.

Sollte die Kommission eine Überprüfung der betreffenden Maßnahmen beschließen, so erhalten die Einführer, die Ausführer, die Vertreter des Ausfuhrlandes und die Gemeinschaftshersteller Gelegenheit, die im Überprüfungsantrag dargelegten Fakten zu ergänzen, zu widerlegen oder zu erläutern.

3.   Frist

Die Gemeinschaftshersteller können nach der Veröffentlichung dieser Bekanntmachung auf der vorgenannten Grundlage einen schriftlichen Antrag auf Überprüfung stellen, der der Europäischen Kommission, Generaldirektion Handel (Referat B-1), J-79 5/16, B-1049 Brüssel (2) spätestens drei Monate vor dem in der untenstehenden Tabelle genannten Zeitpunkt vorliegen muß.

----

(1)ABl. L 56 vom 6.3.1996, S. 1. Verordnung zuletzt geändert durch die Verordnung (EG) Nr. 461/2004 des Rates (ABl. L 77 vom 13.3.2004, S. 12).

(2)  Telefax (32-2) 295 65 05.

----

----

Auszug aus Entscheidungen der Gemeinschaft über die Zulassung von Arzneimitteln vom 1. Juli 2005 bis 31. Juli 2005

(Veröffentlichung gemäß Artikel 12 bzw. Artikel 34 der Verordnung (EWG) Nr. 2309/93 des Rates (1))

(2005/C 209/03)

—   Änderung einer Zulassung (Artikel 12 der Verordnung (EWG) Nr. 2309/93 des Rates): Annahme

—   Erteilung einer Zulassung (Artikel 34 der Verordnung (EWG) Nr. 2309/93 des Rates): Annahme

—   Änderung einer Zulassung (Artikel 34 der Verordnung (EWG) Nr. 2309/93 des Rates): Annahme

Jeder Interessent erhält auf Anfrage einen Bericht über die Beurteilung der betreffenden Arzneimittel sowie die entsprechenden Entscheidungen. Anfragen sind an folgende Adresse zu richten:

----

(1)ABl. L 214 vom 24.8.1993, S. 1.

----
In connection with the First Amendment to Quarterly Report of Daleco Resources
Corporation (the "Company") on Form 10-QSB for the period ending March 31, 2005
(the "Report") amending the Quarterly Report of Daleco Resources Corporation for
the period ending March 31, 2005 dated May 13, 2005, I, Stephan V. Benediktson,
Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. ss. 1350,
as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that:

(1)   The Report fully complies with the requirements of Section 13(a) or 15(d)
      of the Securities Exchange Act of 1934; and

(2)   The information contained in the Report fairly presents, in all material
      respects, the financial condition and result of operations of the Company.


                                        /s/ Stephan V. Benediktson
                                        -------------------------------------
                                        Stephan V. Benediktson
                                        Chief Executive Officer
                                        December 16, 2005
**Exhibit 31.1**

 

**CERTIFICATION OF CO-CHIEF EXECUTIVEOFFICER**

**PURSUANT TO SECTION 302 OF THE SARBANES-OXLEYACT OF 2002**

 

I, Michael A. Reisner, certify that:

 

1.      Ihave reviewed this Annual Report on Form 10-K of ICON Equipment and Corporate Infrastructure Fund Fourteen LiquidatingTrust;

 

2.     Basedon my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessaryto make the statements made, in light of the circumstances under which such statements were made, not misleading with respect tothe period covered by this report;

 

3.    Basedon my knowledge, the financial statements, and other financial information included in this report, fairly present in all materialrespects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presentedin this report;

 

4.    Iam responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) forthe registrant and have:

 

a.    designedsuch disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision,to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me byothers within those entities, particularly during the period in which this report is being prepared;

 

b.    designedsuch internal control over financial reporting, or caused such internal control over financial reporting to be designed undermy supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financialstatements for external purposes in accordance with generally accepted accounting principles;

 

c.    evaluatedthe effectiveness of the registrant's disclosure controls and procedures and presented in this report my conclusions about theeffectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;and

 

d.    disclosedin this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’smost recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected,or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.     Thisreport discloses, based on my most recent evaluation of internal control over financial reporting:

 

a.    all significant deficiencies and material weaknesses in the design or operation of internal control over financial reportingwhich are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information;and

 

b.   any fraud, whether or not material, that involves management or other employees who have a significant role in theregistrant's internal control over financial reporting.

 

Date: March 16, 2020
Justin Devon DIGGS, Appellant, v. STATE of Florida, Appellee.

Case No. 2D15-4650

District Court of Appeal of Florida, Second District.

Opinion filed August 30, 2017.

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
**Exhibit 18(b)**

February 18, 2010 

Oncor Electric Delivery Holdings Company LLC 

1601 Bryan Street 

Dallas, Texas 75201 

Dear Sirs/Madams: 

We have audited theconsolidated financial statements of Oncor Electric Delivery Holdings Company LLC and subsidiaries (“Oncor Holdings”) as of December 31, 2009 and 2008 (successor balance sheets), and for the years ended December 31, 2009 and 2008(successor operations), the period from October 11, 2007 through December 31, 2007 (successor operations) and the period from January 1, 2007 through October 10, 2007 (predecessor operations) of Oncor Electric Delivery CompanyLLC (as Oncor Holdings’ predecessor) , included in Energy Future Intermediate Holding Company LLC’s Annual Report on Form 10-K to the Securities and Exchange Commission and have issued our report thereon dated February 18, 2010 (whichreport expresses an unqualified opinion and includes an explanatory paragraph referring to Oncor Holdings as an indirect subsidiary of Energy Future Holdings Corp., which was merged with Texas Energy Future Merger Sub Corp and becoming a subsidiaryof Texas Energy Future Holdings Limited Partnership on October 10, 2007). Note 1 to such financial statements contains a description of your change, during the year ended December 31, 2009, in the date for the annual goodwill impairmenttest for your reporting unit. In our judgment, such change is to an alternative accounting principle that is preferable under the circumstances. 

Yours truly, 

/s/ Deloitte & Touche LLP 

Dallas, Texas
[Federal Register Volume 74, Number 62 (Thursday, April 2, 2009)]
[Notices]
[Page 14994]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-7198]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Amended Notice of Meeting

    Notice is hereby given of a change in the meeting of the Center for 
Scientific Review Special Emphasis Panel, April 22, 2009, 11 a.m. to 
April 22, 2009, 1 p.m., National Institutes of Health, 6701 Rockledge 
Drive, Bethesda, MD 20892 which was published in the Federal Register 
on March 16, 2009, 74 FR 11120-11121.
    The meeting will be held May 12, 2009. The meeting time and 
location remain the same. The meeting is closed to the public.

    Dated: March 24, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-7198 Filed 4-1-09; 8:45 am]
BILLING CODE 4140-01-M
[Federal Register Volume 74, Number 63 (Friday, April 3, 2009)]
[Notices]
[Pages 15303-15304]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-7366]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Petroleum Environmental Research Forum Project 
No. 2007-05, Membrane Bioreactor Demonstration

    Notice is hereby given that, on February 26, 2009, pursuant to 
Section 6(a) of the National Cooperative Research and Production Act of 
1993, 15 U.S.C. 4301 et seq. (``the Act'') Petroleum Environmental 
Research Forum Project No. 2007-05, Membrane Bioreactor Demonstration 
(``PERF Project No. 2007-05'') has filed written notifications 
simultaneously with the Attorney General and the Federal Trade 
Commission disclosing (1) the identities of the parties to the venture 
and (2) the nature and objectives of the venture. The notifications 
were filed for the purpose of invoking the Act's provisions limiting 
the recovery of antitrust plaintiffs to actual damages under specified 
circumstances.
    Pursuant to Section 6(b) of the Act, the identities of the parties 
to the venture are: ExxonMobil Research and Engineering Company, 
Fairfax, VA; BP Products North America Inc., Naperville, IL; Chevron 
Energy Technology Company, Richmond, CA; ConocoPhillips Company, 
Houston, TX; Repsol YPF S.A., Madrid, SPAIN; and Shell Global Solutions 
(US) Inc., Houston, TX. The general area of PERF Project No. 2007-05's 
planned activity is to, through cooperative research

[[Page 15304]]

efforts, evaluate membrane bioreactor (MBR) technology as a competitive 
alternate to conventional activated sludge system (aeration basin and 
clarifier). This will be done by conducting pilot scale testing of a 
MBR system to treat refinery wastewater alongside conventional 
biological treatment. This setup will allow a quality comparison to be 
conducted. Preferably, both normal conditions as well as various upset 
conditions will be evaluated. Simulated upset conditions to be 
considered may include oil & grease upsets and possibly pH swing, high 
organic or nitrogen loading, and excessive debris or other solids that 
could potentially foul membrane. Current plans are that effluent from 
the MER will be analyzed for potential recycle/reuse applications 
(e.g., cooling tower makeup). The project will attempt to determine if 
this wastewater treatment technology is comparable or superior in 
operability and effluent quality to conventional biological treatment. 
Information regarding participation in this venture may be obtained 
from: Mr. Ryan Couture; ExxonMobil Research and Engineering Company; 
3225 Gallows Road; Fairfax, VA 22037.

Patricia A. Brink,
Deputy Director of Operations, Antitrust Division.
[FR Doc. E9-7366 Filed 4-2-09; 8:45 am]
BILLING CODE 4410-11-M
---

CONSENT

March 31, 2014

VIA EDGAR

United States Securities and Exchange Commission

|Re: | Primero Mining Corp. (the
      "Company") | 
|--- | ------------------------------------------ | 
|    | Annual Report on Form 40-F                 | 
|    | Consent of Expert                          | 

This letter is provided in connection with the Companys annual
report on Form 40-F for the year ended December 31, 2013 to be filed by the
Company with the United States Securities and Exchange Commission and any
amendments thereto (the "Annual Report"). The Annual Report incorporates
by reference the Annual Information Form of the Company for the year ended
December 31, 2013 (the AIF).

I hereby consent to the use of my name in the Annual Report
with reference to my involvement in the review and approval of the scientific
and technical information contained in the following sections of the AIF:

- Mining Activities  San Dimas Mine;
- Mining Activities  Black Box Complex;
- Exploration and Development  Cerro Del Gallo Project
- Mineral Reserves and Resources  San Dimas Mine
- Mineral Reserves and Resources  Cerro Del Gallo Project.

Sincerely,

|/s/ Gabriel Voicu    | 
|-------------------- | 
|Gabriel Voicu, P.Geo | 

---
James WASHINGTON, Appellant, v. STATE of Florida, Appellee.

Case No. 5D16-3743

District Court of Appeal of Florida, Fifth District.

Decision filed November 28, 2017

**DECISION WITHOUT PUBLISHED OPINION**

AFFIRMED.
Scottie L. SCHAEFFER and Melissa Quiros, Appellants, v. WELLS FARGO BANK NATIONAL ASSOCIATION as Trustee FOR STRUCTURED ADJUSTABLE RATE MORTGAGE LOAN TRUST MORTGAGE PASS-THROUGH CERTIFICATES SERIES 2005-20, et al., Appellees.

Case No. 5D17-902

District Court of Appeal of Florida, Fifth District.

Decision filed November 7, 2017 Rehearing Denied December 8, 2017

**DECISION WITHOUT PUBLISHED OPINION**

AFFIRMED.
----

Non-opposition to a notified concentration

(Case COMP/M.3805 — Crompton/Great Lakes)

(2005/C 189/07)

(Text with EEA relevance)

On 15 June 2005, the Commission decided not to oppose the above notified concentration and to declare it compatible with the common market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004. The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

----
Deandre Donell ROBINSON v. STATE

CR-14-1674

Court of Criminal Appeals of Alabama.

October 14, 2016

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
**Exhibit 32.2**

** **

**CERTIFICATIONFURNISHED PURSUANT TO18 U.S.C. SECTION 1350,AS ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

** **

Inconnection with the Quarterly Report on Form 10-Q of Techwell, Inc.(the “Company”) for the quarterly period ended September 30, 2008 as filedwith the Securities and Exchange Commission on the date hereof (the “Report”),Mark Voll, Vice President of Finance and Administration and Chief FinancialOfficer of the Company, hereby certifies, pursuant to 18 U.S.C. Section1350,as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, tothe best of his knowledge, that:

 

(1)   The Report fully complies with therequirements of Section 13(a) or 15(d) of the SecuritiesExchange Act of 1934, as amended; and

 

(2)   The information contained in the Reportfairly presents, in all material respects, the financial condition and resultsof operations of the Company.

 
|   | /s/ Mark Voll                               |
|--------|---------------------------------------------|
|   | Mark Voll                                   |
|   | Vice President of Finance and               |
|   | Administration and Chief  Financial Officer |
|   | November 6, 2008                       |

 

----
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from the
consolidated balance sheet at June 30, 1999 and the consolidated statement of
income for the six months ended June 30, 1999 and is qualified in its entirety
by reference to such financial statements.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               JUN-30-1999
<CASH>                                          10,737
<SECURITIES>                                     4,410
<RECEIVABLES>                                      882
<ALLOWANCES>                                        42
<INVENTORY>                                          0
<CURRENT-ASSETS>                                16,376
<PP&E>                                         173,112
<DEPRECIATION>                                  20,627
<TOTAL-ASSETS>                                 201,915
<CURRENT-LIABILITIES>                            4,665
<BONDS>                                         60,620
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                         74
<COMMON>                                            27
<OTHER-SE>                                     136,630
<TOTAL-LIABILITY-AND-EQUITY>                   201,915
<SALES>                                         10,656
<TOTAL-REVENUES>                                11,378
<CGS>                                                0
<TOTAL-COSTS>                                    6,040
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               1,621
<INCOME-PRETAX>                                  1,176
<INCOME-TAX>                                       508
<INCOME-CONTINUING>                                668
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       668
<EPS-BASIC>                                       0.25
<EPS-DILUTED>                                     0.25


</TABLE>
<PAGE>




                      SURGE COMPONENTS, INC. AND SUBSIDIARY

                                  EXHIBIT 11.2

                    COMPUTATION OF EARNINGS PER COMMON SHARE


<TABLE>
<CAPTION>
                                                          Six Months Ended                           Three Months Ended
                                                               May 31,                                     May 31,
                                                    2000                  1999                    2000                1999
                                                 -----------           -----------            -----------           -----------
<S>                                              <C>                   <C>                    <C>                   <C>
Basic earnings:

Net income                                       $ 1,277,455           $  (163,317)           $   458,371           $   (64,698)

Shares:
    Weighted common shares outstanding             4,931,374             4,857,084              4,973,747             4,858,958
    Convertible notes                                   --                    --                     --                    --
    Employees stock options                             --                    --                     --                    --
                                                 -----------           -----------            -----------           -----------

Total weighted shares outstanding                  4,931,374             4,857,084              4,973,747             4,858,958
                                                 -----------           -----------            -----------           -----------

Basic earnings per common share                  $       .26           $      (.03)           $       .09           $      (.01)
                                                 ===========           ===========            ===========           ===========

Diluted earnings:

Net income                                       $ 1,277,455           $  (163,317)           $   458,371           $   (64,698)

Shares:
    Weighted common shares outstanding             4,931,374             4,857,084              4,973,747             4,858,958
    Convertible notes                                882,826                  --                  882,826                  --
    Employees stock options                        1,902,110                  --                1,902,110                  --
                                                 -----------           -----------            -----------           -----------

Total weighted shares outstanding                  7,716,310             4,857,084              7,758,683             4,858,958
                                                 -----------           -----------            -----------           -----------

Diluted earnings per common share                $       .17           $      (.03)           $       .06           $      (.01)
                                                 ===========           ===========            ===========           ===========
</TABLE>
M.D.F., a child, Appellant, v. STATE of Florida, Appellee.

No. 4D16-1092

District Court of Appeal of Florida, Fourth District.

November 9, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
Kenneth James HETTEL, Appellant, v. CSX TRANSPORTATION, INC., f/k/a Seaboard Coastline Railroad, Appellee.

Case No. 2D16-4306

District Court of Appeal of Florida, Second District.

Opinion filed August 18, 2017.

**DECISION WITHOUT PUBLISHED OPINION**

Dismissed.
EXHIBIT 32
----------




                           CERTIFICATIONS OF
          CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
            PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED
       PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
       ---------------------------------------------------------



     The following statement is provided by the undersigned to accompany
the Quarterly Report on Form 10-Q for the quarter ended March 31, 2009,
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be
deemed filed pursuant to any provision of the Securities Exchange Act of
1934 or any other securities law:

     Each of the undersigned certifies that the foregoing Report on
Form 10-Q fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934 (15 U.S.C. 78m) and that the
information contained in the Form 10-Q fairly presents, in all material
respects, the financial condition and results of operations of JMB/245 PARK
AVENUE ASSOCIATES, LTD.





By: /s/ Patrick J. Meara          By: /s/ Gailen J. Hull
    ----------------------            ----------------------------
    Patrick J. Meara                  Gailen J. Hull
    Chief Executive Officer           Chief Financial Officer and
                                      Principal Accounting Officer
R.B.H., Appellant, v. STATE of Florida, Appellee.

Case No. 2D16-4962

District Court of Appeal of Florida, Second District.

Opinion filed September 1, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.